vs

Side-by-side financial comparison of Ardmore Shipping Corp (ASC) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $81.2M, roughly 1.6× Ardmore Shipping Corp). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -15.5%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs -6.0%).

Ardmore Shipping Corp is a global maritime transport company that owns and operates a fleet of mid-sized product and chemical tankers. It provides seaborne transport for petroleum products, specialty chemicals and bulk liquid commodities, serving energy, chemical and trading clients across key international trade routes.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

ASC vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.6× larger
ZLAB
$127.1M
$81.2M
ASC
Growing faster (revenue YoY)
ZLAB
ZLAB
+32.6% gap
ZLAB
17.1%
-15.5%
ASC
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
-6.0%
ASC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASC
ASC
ZLAB
ZLAB
Revenue
$81.2M
$127.1M
Net Profit
$12.8M
Gross Margin
51.0%
Operating Margin
16.1%
-54.6%
Net Margin
15.7%
Revenue YoY
-15.5%
17.1%
Net Profit YoY
-47.0%
EPS (diluted)
$0.30
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASC
ASC
ZLAB
ZLAB
Q4 25
$127.1M
Q3 25
$81.2M
$115.4M
Q2 25
$72.0M
$109.1M
Q1 25
$74.0M
$105.7M
Q4 24
$108.5M
Q3 24
$96.1M
$101.8M
Q2 24
$121.3M
$100.1M
Q1 24
$106.3M
$87.1M
Net Profit
ASC
ASC
ZLAB
ZLAB
Q4 25
Q3 25
$12.8M
$-36.0M
Q2 25
$9.6M
$-40.7M
Q1 25
$6.3M
$-48.4M
Q4 24
Q3 24
$24.1M
$-41.7M
Q2 24
$62.7M
$-80.3M
Q1 24
$39.2M
$-53.5M
Gross Margin
ASC
ASC
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
ASC
ASC
ZLAB
ZLAB
Q4 25
-54.6%
Q3 25
16.1%
-42.3%
Q2 25
13.5%
-50.3%
Q1 25
8.6%
-53.3%
Q4 24
-62.6%
Q3 24
25.4%
-66.6%
Q2 24
51.3%
-76.0%
Q1 24
37.2%
-80.7%
Net Margin
ASC
ASC
ZLAB
ZLAB
Q4 25
Q3 25
15.7%
-31.2%
Q2 25
13.3%
-37.3%
Q1 25
8.5%
-45.8%
Q4 24
Q3 24
25.1%
-40.9%
Q2 24
51.7%
-80.2%
Q1 24
36.9%
-61.4%
EPS (diluted)
ASC
ASC
ZLAB
ZLAB
Q4 25
$-0.05
Q3 25
$0.30
$-0.03
Q2 25
$0.22
$-0.04
Q1 25
$0.14
$-0.04
Q4 24
$-0.09
Q3 24
$0.55
$-0.04
Q2 24
$1.47
$-0.08
Q1 24
$0.92
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASC
ASC
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$689.6M
Total DebtLower is stronger
$116.1M
Stockholders' EquityBook value
$628.2M
$715.5M
Total Assets
$799.8M
$1.2B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASC
ASC
ZLAB
ZLAB
Q4 25
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$757.3M
Q4 24
$779.7M
Q3 24
$616.1M
Q2 24
$630.0M
Q1 24
$650.8M
Total Debt
ASC
ASC
ZLAB
ZLAB
Q4 25
Q3 25
$116.1M
Q2 25
$25.0M
Q1 25
$20.5M
Q4 24
Q3 24
$22.5M
Q2 24
$44.2M
Q1 24
$23.1M
Stockholders' Equity
ASC
ASC
ZLAB
ZLAB
Q4 25
$715.5M
Q3 25
$628.2M
$759.9M
Q2 25
$618.3M
$791.7M
Q1 25
$610.7M
$810.8M
Q4 24
$840.9M
Q3 24
$627.0M
$667.7M
Q2 24
$617.7M
$704.2M
Q1 24
$567.9M
$762.2M
Total Assets
ASC
ASC
ZLAB
ZLAB
Q4 25
$1.2B
Q3 25
$799.8M
$1.2B
Q2 25
$703.8M
$1.2B
Q1 25
$690.4M
$1.2B
Q4 24
$1.2B
Q3 24
$722.8M
$985.3M
Q2 24
$742.0M
$987.4M
Q1 24
$704.1M
$988.4M
Debt / Equity
ASC
ASC
ZLAB
ZLAB
Q4 25
Q3 25
0.18×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
0.04×
Q2 24
0.07×
Q1 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASC
ASC
ZLAB
ZLAB
Operating Cash FlowLast quarter
$17.9M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
1.40×
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASC
ASC
ZLAB
ZLAB
Q4 25
$-26.0M
Q3 25
$17.9M
$-32.0M
Q2 25
$11.2M
$-31.0M
Q1 25
$26.3M
$-61.7M
Q4 24
$-55.8M
Q3 24
$39.9M
$-26.8M
Q2 24
$48.4M
$-42.2M
Q1 24
$49.2M
$-90.1M
Free Cash Flow
ASC
ASC
ZLAB
ZLAB
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
Q1 24
$-91.1M
FCF Margin
ASC
ASC
ZLAB
ZLAB
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Q1 24
-104.5%
Capex Intensity
ASC
ASC
ZLAB
ZLAB
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Q1 24
1.1%
Cash Conversion
ASC
ASC
ZLAB
ZLAB
Q4 25
Q3 25
1.40×
Q2 25
1.17×
Q1 25
4.20×
Q4 24
Q3 24
1.65×
Q2 24
0.77×
Q1 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASC
ASC

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons